Get Your Free Audiobook
-
Illumina's Bid to Beat Cancer with DNA Tests
- Narrated by: Todd Mundt
- Length: 6 mins
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
New to Audible Prime Member exclusive:
2 credits with free trial
2 credits with free trial
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199 per month after 30-day trial. Cancel anytime.
Buy Now for ₹65.00
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice.
Publisher's Summary
The world’s largest DNA sequencing company says it will form a new company to develop blood tests that cost $1,000 or less and can detect many types of cancer before symptoms arise. Illumina, based in San Diego, said its blood tests should reach the market by 2019, and would be offered through doctors’ offices or possibly a network of testing centers.
©2016 Massachusetts Institute of Technology (P)2016 Massachusetts Institute of Technology